Some Possibilities to Study New Prophylactics against Nerve Agents

Author(s): J. Bajgar, J. Kassa, T. Kucera, K. Musilek, D. Jun, K. Kuca*.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 19 , Issue 12 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Nerve agents belong to the most dangerous chemical warfare agents and can be/were misused by terrorists. Effective prophylaxis and treatment is necessary to diminish their effect. General principles of prophylaxis are summarized (protection against acetylcholinesterase inhibition, detoxification, treatment “in advance” and use of different drugs). They are based on the knowledge of mechanism of action of nerve agents. Among different examinations, it is necessary to test prophylactic effectivity in vivo and compare the results with protection in vitro. Chemical and biological approaches to the development of new prophylactics would be applied simultaneously during this research. Though the number of possible prophylactics is relatively high, the only four drugs were introduced into military medical practice. At present, pyridostigmine seems to be common prophylactic antidote; prophylactics panpal (tablets with pyridostigmine, trihexyphenidyl and benactyzine), transant (transdermal patch containing HI-6) are other means introduced into different armies as prophylactics. Scavenger commercionally available is Protexia®. Future development will be focused on scavengers, and on other drugs either reversible cholinesterase inhibitors (e.g., huperzine A, gallantamine, physostigmine, acridine derivatives) or other compounds.

Keywords: Nerve agents, prophylaxis, scavengers, antidotes, cholinesterases, in vitro, in vivo.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [970 - 979]
Pages: 10
DOI: 10.2174/1389557519666190301112530
Price: $58

Article Metrics

PDF: 8